Privia Health Group, Inc. · NASDAQ:PRVA

Privia Health — J.P. Morgan Healthcare Conference 2022

14 slides from Privia Health's conference presentation, Jan 10, 2022

  1. Slide 1: J.P. Morgan Healthcare Conference – Empowering Physicians, Transforming Healthcare

    PROPRIETARY AND CONFIDENTIAL J.P. Morgan Healthcare Conference January 10, 2022 Empowering Physicians TRANSFORMING HEALTHCARE

  2. Slide 2: Forward-Looking Statements

    2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. These forward-looking statements involve a number of risks, uncertai

  3. Slide 3: Who is Privia Health?

    3 Who is Privia Health? Privia Health is building the leading next generation physician organization and care delivery network Our revolutionary business model is comprised of three interdependent elements:  Single TIN Medical Group  Risk-Bearing Entity  Tech-Enabled Clinical and Performance Oper

  4. Slide 4: Building a National Footprint

    4 Building a National Footprint Privia Timeline Launched Mid-Atlantic Market Launched Women’s Health Platform Launched Tennessee Market & Privia Pediatrics Platform Launched North Texas Market Launched Georgia & South Texas Markets Launched Florida Market Launched First Practice Current Market Prese

  5. Slide 5: Moving Markets Toward Value-Based Care At Scale

    5 Moving Markets Toward Value-Based Care At Scale Enter Market  Align with anchor medical groups and health systems to transition markets to value-based care Organize Providers  Form high performance medical groups  Develop network of leading primary care providers and specialists Drive Improveme

  6. Slide 6: High-Performing Value-Based Platform Across Reimbursement Models

    6 High-Performing Value-Based Platform Across Reimbursement Models 70+ At Risk Payer Contracts 760K1 Total Attributed Lives 286K Government Lives 474K Commercial Lives 103K Medicare Advantage Lives 141K MSSP & MDPCP Lives 42K Medicaid Lives 1 Attributed lives as of 9-30-2021

  7. Slide 7: Delivering Demonstrable Value to Our Providers

    7 Delivering Demonstrable Value to Our Providers Fee-for-Service Rate Lift Expense Savings on EMR / PMS & Group Purchasing Net Realization Rate Improvement Through Robust Revenue Cycle Management Enhanced Provider Productivity & Same- Store Patient Volume Value-Based Care Revenue: Commercial, MSSP,

  8. Slide 8: Ability to Influence Outcomes Without Ownership of Underlying Practice

    8 Ability to Influence Outcomes Without Ownership of Underlying Practice  Single medical group by market  Single contracting entity & common risk pools  Physician-led governance  Integrated technology and clinical operations  Financial alignment with physicians (no risk backstop)  Preserves ph

  9. Slide 9: Methodical Process Helps Providers Move Towards Value

    9 Methodical Process Helps Providers Move Towards Value Practice Fundamentals Stabilize the practice to create a successful base Enhanced Experience Upgrade the patient experience Fundamentals of Value Execute on fundamentals of value-based care Comprehensive Care Take greater responsibility for the

  10. Slide 10: Proprietary, End-to-End Tech Solution Enables Providers to Practice More Efficiently

    10 Proprietary, End-to-End Tech Solution Enables Providers to Practice More Efficiently and Focus on Patient Care Proprietary end-to-end, cloud-based technology solution enabling scalable operations across providers and multiple markets Enhances workflows in both fee-for-service and value-based care

  11. Slide 11: Positioned to Monetize Our Platform and Drive Growth

    11 Positioned to Monetize Our Platform and Drive Growth — Same store growth of patients attributed to value based contracts — Moving existing attribution into full risk value based programs, such as direct contracting and fully capitated contracts — Develop new products with aligned payers — Add pri

  12. Slide 12: Confirming FY'21 Guidance

    12 Confirming FY’21 Guidance ($ in millions) Initial Guidance (5.27.21) Revised Guidance (8.9.21) Updated Guidance (11.8.21) Low High Low High Implemented Providers 2,850 2,900 Mid-to-High End 3,300 3,330 Attributed Lives 730,000 750,000 High End 760,000 765,000 Practice Collections $ 1,445 $ 1,465

  13. Slide 13: Privia Health: Investment Highlights

    13 Privia Health: Investment Highlights Proven and Scalable for All Provider Types, Patients & Reimbursement Models Multiple Drivers for Future Growth with a Large TAM Comprehensive Technology Solution Built for Providers Profitable, Capital-Efficient Profile Aligned with Provider Financial Success

  14. Slide 14: Thank You

    14 Thank You PriviaHealth.com Contact: Robert P. Borchert SVP, Investor & Corporate Communications robert.borchert@priviahealth.com Phone: 817.783.4841

Privia Health Group — J.P. Morgan Healthcare Conference 2022 on 6ix